Recent studies have shown that nerve growth factor (NGF) can improve learning and memory in animals with injury- or age-related neurodegeneration. However, little information exists regarding the effects of another neurotrophin, brain-derived neurotrophic factor (BDNF). Previous pharmacological approaches seemed to show that BDNF was not efficacious at improving cognition in aged, spatial learning- impaired animals. An alternative interpretation of the results os that BDNF does not diffuse well from the ventricles into the surrounding parenchyma. The present study attempts to use a genetic approach to investigate the potential effects of BDNF on learning and memory deficits in aged mice. The hypotheses to be tested are: 1) over- expression of BDNF in the cerebral cortex and hippocampus in aged mice could prevent atrophy of forebrain cholinergic neurons in vivo.2 ). Over-expression of BDNF in the cerebral cortex and hippocampus could improve spatial learning and memory in aged mice. To test the above hypothesis, the following specific aims are proposed: 1) Make tetO- BDNF/Emx1-cre mice. 2). Assess the ability of BDNF to sustain the phenotype of forebrain cholinergic neurons in aged mice brains through immunohistochemistry. 3). Determine whether the over-expression of the BDNF gene in the cerebral cortex and hippocampus would improve learning and memory in aged mice using the Morris water maze task. The research design uses bacterial recombinase Cre-mediated deletion and tetracycline regulated system in mice to over-express BDNF in the cerebral cortex and hippocampus and to study the consequences of the over-expression upon mutant animals' behavior and anatomy in aged brains. The health-relatedness of the project is that the results of the study will allow us to clarify the potential role of BDNF in the clinical therapy of neurodegenerative diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Small Research Grants (R03)
Project #
1R03AG017291-01
Application #
6012314
Study Section
Special Emphasis Panel (ZAG1-PCR-5 (M9))
Project Start
1999-08-01
Project End
2000-07-31
Budget Start
1999-08-01
Budget End
2000-07-31
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Illinois Urbana-Champaign
Department
Physiology
Type
Schools of Arts and Sciences
DUNS #
041544081
City
Champaign
State
IL
Country
United States
Zip Code
61820
DeAndrade, Mark P; Yokoi, Fumiaki; van Groen, Thomas et al. (2011) Characterization of Atp1a3 mutant mice as a model of rapid-onset dystonia with parkinsonism. Behav Brain Res 216:659-65
Yokoi, Fumiaki; Yang, Guang; Li, Jindong et al. (2010) Earlier onset of motor deficits in mice with double mutations in Dyt1 and Sgce. J Biochem 148:459-66
Mitsui, Shinichi; Osako, Yoji; Yokoi, Fumiaki et al. (2009) A mental retardation gene, motopsin/neurotrypsin/prss12, modulates hippocampal function and social interaction. Eur J Neurosci 30:2368-78
Dang, Mai T; Yokoi, Fumiaki; Yin, Henry H et al. (2006) Disrupted motor learning and long-term synaptic plasticity in mice lacking NMDAR1 in the striatum. Proc Natl Acad Sci U S A 103:15254-9
Skurk, Carsten; Maatz, Henrike; Kim, Hyo-Soo et al. (2004) The Akt-regulated forkhead transcription factor FOXO3a controls endothelial cell viability through modulation of the caspase-8 inhibitor FLIP. J Biol Chem 279:1513-25
Campos, Victor E; Du, Mengyuan; Li, Yuqing (2004) Increased seizure susceptibility and cortical malformation in beta-catenin mutant mice. Biochem Biophys Res Commun 320:606-14
Cao, Bo-Jin; Li, Yuqing (2002) Reduced anxiety-- and depression-like behaviors in Emx1 homozygous mutant mice. Brain Res 937:32-40
Guo, H; Christoff, J M; Campos, V E et al. (2000) Normal corpus callosum in Emx1 mutant mice with C57BL/6 background. Biochem Biophys Res Commun 276:649-53
Guo, H; Hong, S; Jin, X L et al. (2000) Specificity and efficiency of Cre-mediated recombination in Emx1-Cre knock-in mice. Biochem Biophys Res Commun 273:661-5